Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Baris, Safa  [Clear All Filters]
2023
Erdem S, Haskoloğlu Ş, Haliloglu Y, Çelikzencir H, Arik E, Keskin O, Eltan SBilgic, Yucel E, Canatan H, Avcilar H, et al. Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1. Clin Immunol. 2023:109691.
Yakici N, Kreins AY, Catak MCihangir, Babayeva R, Erman B, Kenney H, Gungor HEke, Cea PA, Kawai T, Bosticardo M, et al. Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients. Clin Immunol. 2023:109757.
Labrosse R, Chu J, Armant M, Everett JK, Pellin D, Kareddy N, Frelinger AL, Henderson LA, O'Connell AE, Biswas A, et al. Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome. Blood. 2023.
2022
Jamee M, Azizi G, Baris S, Karakoc-Aydiner E, Ozen A, Kilic SS, Kose H, Chavoshzadeh Z, Mahdaviani SAlireza, Momen T, et al. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry. Clin Immunol. 2022:109131.
Leiding JW, Vogel TP, Santarlas VGJ, Mhaskar R, Smith MR, Carisey A, Vargas-Hernández A, Silva-Carmona M, Heeg M, Rensing-Ehl A, et al. Monogenic Early-Onset Lymphoproliferation and Autoimmunity: The Natural History of STAT3 GOF Syndrome. J Allergy Clin Immunol. 2022.
Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, Luo J, Yang W, Perner SP, Kanellopoulou C, et al. Mucus sialylation determines intestinal host-commensal homeostasis. Cell. 2022.
2021
Aydiner EKarakoc, Eltan SBilgic, Babayeva R, Aydiner O, Kepenekli E, Kolukisa B, Sefer APinar, Gungoren EYalcin, Karabiber E, Yucel EOzek, et al. Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses. Allergy. 2021.
Kayaoglu B, Kasap N, Yilmaz NSurucu, Charbonnier LMarie, Geckin B, Akçay A, Eltan SBilgic, Öztürk G, Ozen A, Karakoc-Aydiner E, et al. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. J Clin Immunol. 2021.
2020
Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, Camacho-Ordonez N, Varjosalo M, Kinnunen M, de Vries E, et al. Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020.
Baris HEzgi, Ogulur I, Akcam B, Kiykim A, Karagoz D, Saraymen B, Akgun G, Eltan SBilgic, Aydemir S, Akidagi Z, et al. Diagnostic modalities based on flow cytometry for chronic granulomatous disease: a multicenter study in a well-defined cohort. J Allergy Clin Immunol Pract. 2020.
2019
Tesch VKatharina, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière JG, Garcia-Prat M, Moes N, et al. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. 2019.